Your browser doesn't support javascript.
loading
Targeting IL-1 controls refractory pityriasis rubra pilaris.
Schmauch, Eloi; Severin, Yannik; Xing, Xianying; Mangold, Aaron; Conrad, Curdin; Johannsen, Pål; Kahlenberg, J Michelle; Mellett, Mark; Navarini, Alexander; Nobbe, Stefan; Sarkar, Mrinal K; Satyam, Abhigyan; Tsoi, Lam C; French, Lars E; Nilsson, Jakob; Linna-Kuosmanen, Suvi; Kaikkonen, Minna U; Snijder, Berend; Kellis, Manolis; Gudjonsson, Johann E; Tsokos, George C; Contassot, Emmanuel; Kolios, Antonios G A.
Affiliation
  • Schmauch E; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Severin Y; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Xing X; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
  • Mangold A; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, 8049 Zurich, Switzerland.
  • Conrad C; Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor, MI 48109, USA.
  • Johannsen P; Department of Dermatology, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA.
  • Kahlenberg JM; Department of Dermatology, CHUV University Hospital and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Mellett M; Department of Dermatology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.
  • Navarini A; Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor, MI 48109, USA.
  • Nobbe S; Department of Dermatology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.
  • Sarkar MK; Department of Biomedicine and Dermatology Department, University Hospital of Basel, Basel, Switzerland.
  • Satyam A; Department of Dermatology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.
  • Tsoi LC; Department of Dermatology, Cantonal Hospital Frauenfeld, Frauenfeld, Switzerland.
  • French LE; Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor, MI 48109, USA.
  • Nilsson J; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Linna-Kuosmanen S; Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor, MI 48109, USA.
  • Kaikkonen MU; Department of Dermatology and Allergology, Ludwig Maximilian University of Munich, Munich, Germany.
  • Snijder B; Dr. Philip Frost, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL 33125, USA.
  • Kellis M; Department of Immunology, University Hospital Zurich, Zurich, Switzerland.
  • Gudjonsson JE; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Tsokos GC; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
  • Contassot E; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
  • Kolios AGA; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, 8049 Zurich, Switzerland.
Sci Adv ; 10(27): eado2365, 2024 Jul 05.
Article de En | MEDLINE | ID: mdl-38959302

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pityriasis rubra pilaire / Kératinocytes / Antagoniste du récepteur à l'interleukine-1 / Interleukine-1 bêta / Anticorps monoclonaux humanisés Langue: En Journal: Sci Adv Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pityriasis rubra pilaire / Kératinocytes / Antagoniste du récepteur à l'interleukine-1 / Interleukine-1 bêta / Anticorps monoclonaux humanisés Langue: En Journal: Sci Adv Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique